• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞色素P450 2C9和2C19酶抑制剂的亲脂性相关性

Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymes.

作者信息

Lewis David F V, Lake Brian G, Ito Yuko, Dickins Maurice

机构信息

School of Biomedical and Molecular Sciences University of Surrey, Guildford, Surrey, GU2 XH, UK.

出版信息

J Enzyme Inhib Med Chem. 2006 Aug;21(4):385-9. doi: 10.1080/14756360600703313.

DOI:10.1080/14756360600703313
PMID:17059170
Abstract

Quantitative structure-activity relationships (QSARs) within a series of cytochrome P450 2C9 (CYP2C9) and cytochrome P450 2C19 (CYP2C19) inhibitors are reported. In particular, it is noted that compound lipophilicity, in the form of log P values (where P is the octanol/water partition coefficient), is an important factor in explaining the variation in inhibitory potency within these series of compounds, many of which also act as substrates for the respective enzymes. In addition, there is a role for hydrogen bonding and pi-pi stacking interactions within the P450 active site which represent secondary factors in the binding processes of these compounds.

摘要

报道了一系列细胞色素P450 2C9(CYP2C9)和细胞色素P450 2C19(CYP2C19)抑制剂的定量构效关系(QSAR)。特别需要指出的是,以log P值(其中P为正辛醇/水分配系数)形式表示的化合物亲脂性,是解释这些系列化合物抑制效力变化的一个重要因素,其中许多化合物也是相应酶的底物。此外,P450活性位点内的氢键和π-π堆积相互作用也发挥了作用,它们是这些化合物结合过程中的次要因素。

相似文献

1
Lipophilicity relationships in inhibitors of CYP2C9 and CYP2C19 enzymes.细胞色素P450 2C9和2C19酶抑制剂的亲脂性相关性
J Enzyme Inhib Med Chem. 2006 Aug;21(4):385-9. doi: 10.1080/14756360600703313.
2
Active-site characteristics of CYP2C19 and CYP2C9 probed with hydantoin and barbiturate inhibitors.用乙内酰脲和巴比妥酸盐抑制剂探究CYP2C19和CYP2C9的活性位点特征。
Arch Biochem Biophys. 2004 Sep 1;429(1):1-15. doi: 10.1016/j.abb.2004.05.015.
3
Quantitative structure-activity relationships (QSARs) for inhibitors and substrates of CYP2B enzymes: importance of compound lipophilicity in explanation of potency differences.CYP2B 酶抑制剂和底物的定量构效关系(QSARs):化合物脂溶性在解释效价差异中的重要性。
J Enzyme Inhib Med Chem. 2010 Oct;25(5):679-84. doi: 10.3109/14756360903514149.
4
Sulfaphenazole derivatives as tools for comparing cytochrome P450 2C5 and human cytochromes P450 2Cs: identification of a new high affinity substrate common to those enzymes.磺胺苯唑衍生物作为比较细胞色素P450 2C5和人细胞色素P450 2C家族的工具:鉴定这些酶的一种新的高亲和力共同底物。
Biochemistry. 2003 Jun 3;42(21):6363-9. doi: 10.1021/bi027391+.
5
Quantitative structure-activity relationships (QSARs) in inhibitors of various cytochromes P450: the importance of compound lipophilicity.
J Enzyme Inhib Med Chem. 2007 Feb;22(1):1-6. doi: 10.1080/14756360600952183.
6
Structural characterization of human cytochrome P450 2C19: active site differences between P450s 2C8, 2C9, and 2C19.人细胞色素 P450 2C19 的结构特征:P450s 2C8、2C9 和 2C19 的活性部位差异。
J Biol Chem. 2012 Dec 28;287(53):44581-91. doi: 10.1074/jbc.M112.424895. Epub 2012 Nov 1.
7
Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.人肝微粒体中细胞色素P450 2C19、2C9和3A4对孕酮和睾酮的羟基化作用。
Arch Biochem Biophys. 1997 Oct 1;346(1):161-9. doi: 10.1006/abbi.1997.0302.
8
Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymes.对人CYP2家族酶的底物结合亲和力和选择性的基本要求。
Arch Biochem Biophys. 2003 Jan 1;409(1):32-44. doi: 10.1016/s0003-9861(02)00349-1.
9
3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design.细胞色素P450 2C19的三维结构建模及其在个性化药物设计中的意义。
Biochem Biophys Res Commun. 2007 Apr 6;355(2):513-9. doi: 10.1016/j.bbrc.2007.01.185. Epub 2007 Feb 8.
10
Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.人肝脏中CYP2C19和CYP2C9的特性:在微粒体甲苯磺丁脲、S-美芬妥因和奥美拉唑羟化反应中的各自作用。
Arch Biochem Biophys. 1998 May 1;353(1):16-28. doi: 10.1006/abbi.1998.0615.

引用本文的文献

1
In vitro evaluation of tropolone absorption, metabolism, and clearance.体外评估曲通醇的吸收、代谢和清除。
Antiviral Res. 2023 Dec;220:105762. doi: 10.1016/j.antiviral.2023.105762. Epub 2023 Nov 22.
2
Substituted 1,2,3-triazoles: a new class of nitrification inhibitors.取代 1,2,3-三唑类:一类新型硝化抑制剂。
Sci Rep. 2021 Jul 22;11(1):14980. doi: 10.1038/s41598-021-94306-1.
3
Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs.细胞色素抑制剂的描述以及基于机器学习的更安全药物设计实用方法
Pharmaceuticals (Basel). 2021 May 17;14(5):472. doi: 10.3390/ph14050472.
4
Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance.顺铂类似物与环氧合酶抑制剂的缀合以克服顺铂耐药性。
ChemMedChem. 2015 Jan;10(1):183-92. doi: 10.1002/cmdc.201402353. Epub 2014 Oct 15.
5
Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies.通过定量构效关系研究获得的细胞色素 p450 酶和抑制剂的见解。
Molecules. 2012 Aug 3;17(8):9283-305. doi: 10.3390/molecules17089283.